Approved by the U.S. Food and Drug Administration (FDA) in 1999, the Type 2 diabetes drug Actos (pioglitazone) was one of Takeda Pharmaceuticals’ best-selling drugs. With diet and exercise, it helps control blood sugar. But, it is also a controversial drug that is linked to a number of serious side effects, including congestive heart failure, kidney disease and bladder cancer.
Eli Lilly partnered with Takeda to market the drug, and it became one of the most successful diabetes medications of all time. Before the manufacturer lost the patent on Actos in 2011, its U.S. sales were $3.58 billion in 2010. The drug’s sales made up 27 percent of the manufacturer’s revenue.
Actos is a member of a family of drugs called thiazolidinediones (TZDs) that are known for severe side effects. Another drug in the same family is the Type 2 diabetes drug Avandia (rosiglitazone). The FDA temporarily placed heavy restrictions on the drug because of concerns over heart attacks.
TZDs are known to cause heart failure and other heart problems. In fact, Actos has a black-box warning for congestive heart failure, and people with a history of heart failure should not use the drug.
But, it is a possible side effect unique to Actos that now raises concern: bladder cancer. In August 2011, the FDA required that Takeda update the drug’s Warnings and Precautions section of the label to include a warning that use of the drug for over a year may be associated with an increased risk of bladder cancer.
Thousands of patients filed lawsuits against Takeda after doctors diagnosed them with the deadly disease. The lawsuits state Takeda knew of the dangers of the drug and failed to adequately warn patients, putting profit before patient’s safety.
Free Bladder Cancer Case Review
If you have bladder cancer after using Actos, ask about your legal options.
What Is Actos?
Actos is an oral Type 2 diabetes drug that comes in tablet form. It is not for use in treatment of Type 1 diabetes or diabetic ketoacidosis. Typically, the dose starts at 15 or 30 mg and is taken once a day. Some people may require a stronger dose, and doctors can increase the strength of the medicine by 15 mg increments. The maximum recommended dose of the drug is 45 mg.
This medicine works by decreasing insulin resistance and decreasing the glucose made in the liver. This allows the body to better dispose of excess blood sugar and makes the body’s cells more sensitive to insulin.
The drug can be used alone or with other Type 2 diabetes medicines like metformin.
Bladder Cancer Risk
BMJ published the latest study on pioglitazone in May 2012. This study revealed that people who take Actos for an extended period have an 83 percent higher risk of developing bladder cancer.
Before 2012, a few studies – including Takeda’s own preclinical trials – already linked the drug to bladder problems. In animal studies, male rats suffered from bladder tumors after receiving the drug.
According to the FDA, in two additional three-year studies (a liver safety study and the PROactive study) researchers noted a higher incidence of bladder cancer in patients who took Actos versus those who took other drugs. As a result of these studies, the FDA required that Takeda undertake a 10-year study of the drug’s link to bladder cancer.
The FDA will review the data once it is available to further evaluate the drug’s safety.
|Bladder Cancer Symptoms|
You should contact your doctor immediately if you experience any symptoms that may indicate bladder cancer:
|Pain when urinating|
|Increased urge to urinate|
|Unusual back pain|
Black-Box Warning for Congestive Heart Failure
Actos has a black-box warning for congestive heart failure. TZDs are known to cause or worsen this condition. Symptoms of congestive heart failure include:
- Excessive, rapid weight gain
- Difficulty breathing (dyspnea)
- Fluid retention and swelling (edema)
Patients with a history of heart failure should be monitored when taking Actos. This medicine is also not recommended for patients with symptomatic heart failure or stage III or IV heart failure.
Other Side Effects
Chronic Kidney Disease
Researchers from Taiwan’s Kaohsiung Medical University published a study in PLoS One that found the Type 2 diabetes drug increased the risk of chronic kidney disease. The study followed 35,000 people with diabetes from 2005 to 2009. People who took Actos were four times more likely to develop kidney disease than those who did not.
Lactic Acidosis and Bone Fracture
Actos also carries a warning for the risk of developing lactic acidosis.
|Lactic acidosis is a potentially fatal condition with symptoms of:|
|Stomach discomfort||Decreased appetite|
|Muscle pain or cramping||Sleepiness|
Women who take Actos are susceptible to developing bone fractures, especially in the hands, feet, ankles and lower legs.
Among patients who took Actos, there were reports of some fatal and nonfatal cases of liver failure. According to the drug’s warnings and precautions insert, there is no way to definitively prove that it does not cause liver issues.
Still, doctors should test each patient’s liver prior to prescribing the drug and monitor each patient for signs of liver damage, including:
- Upper abdominal discomfort
- Dark urine
- Yellowing of the skin or eyes (jaundice)
|You should always inform your doctor of any medical conditions, especially the following:|
|Any diabetes issues such as macular edema or a history of diabetic ketoacidosis|
|Heart problems or severe heart failure|
|Type 1 diabetes|
|Active bladder cancer or a history of bladder cancer|
|Pregnancy or plans to become pregnant|
You should discuss any medications, supplements or vitamins that you are currently taking with your doctor. Also inform your health care provider if you smoke, drink or use illegal drugs.
Lawsuits Against Takeda
Thousands of people who took the drug filed lawsuits against Takeda Pharmaceuticals and Elli Lilly after doctors diagnosed them with bladder cancer.
In the first federal trial, a Louisiana jury awarded $9 billion in punitive damages and $1.5 million in compensatory damages to Terrence Allen, a former shopkeeper from New York who said Actos caused his bladder cancer. Allen’s lawyers argued that the company “was more concerned with making money” than watching out for patient safety.
If you or a loved one took Actos and developed bladder cancer, Drugwatch can help you decide if filing a lawsuit is an option for you. Call (800) 452-0949 to speak to a patient advocate.